Biopharma Insights-Thought Leadership from Marketers | Sponsored Content | Cygnus Technologies
Viral contamination is an inherent risk during the manufacture of therapeutic products such as antibodies, vaccines, viral vectors, and plasma derivates.
Advertisement
Advertisement
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Accelerate Your Biologic with HEK Cell Lines
4